IBDEI1GB ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,23208,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23208,1,3,0)
 ;;=3^Nonobstructive Reflux-Associated Chronic Pyelonephritis
 ;;^UTILITY(U,$J,358.3,23208,1,4,0)
 ;;=4^N11.0
 ;;^UTILITY(U,$J,358.3,23208,2)
 ;;=^5015571
 ;;^UTILITY(U,$J,358.3,23209,0)
 ;;=N11.8^^105^1170^23
 ;;^UTILITY(U,$J,358.3,23209,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23209,1,3,0)
 ;;=3^Tubulo-Interstitial Nephritis,Chronic NEC
 ;;^UTILITY(U,$J,358.3,23209,1,4,0)
 ;;=4^N11.8
 ;;^UTILITY(U,$J,358.3,23209,2)
 ;;=^5015573
 ;;^UTILITY(U,$J,358.3,23210,0)
 ;;=N30.90^^105^1170^8
 ;;^UTILITY(U,$J,358.3,23210,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23210,1,3,0)
 ;;=3^Cystitis w/o Hematuria,Unspec
 ;;^UTILITY(U,$J,358.3,23210,1,4,0)
 ;;=4^N30.90
 ;;^UTILITY(U,$J,358.3,23210,2)
 ;;=^5015642
 ;;^UTILITY(U,$J,358.3,23211,0)
 ;;=N32.0^^105^1170^1
 ;;^UTILITY(U,$J,358.3,23211,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23211,1,3,0)
 ;;=3^Bladder-Neck Obstruction
 ;;^UTILITY(U,$J,358.3,23211,1,4,0)
 ;;=4^N32.0
 ;;^UTILITY(U,$J,358.3,23211,2)
 ;;=^5015649
 ;;^UTILITY(U,$J,358.3,23212,0)
 ;;=N31.9^^105^1170^18
 ;;^UTILITY(U,$J,358.3,23212,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23212,1,3,0)
 ;;=3^Neuromuscular Bladder Dysfunction,Unspec
 ;;^UTILITY(U,$J,358.3,23212,1,4,0)
 ;;=4^N31.9
 ;;^UTILITY(U,$J,358.3,23212,2)
 ;;=^5015648
 ;;^UTILITY(U,$J,358.3,23213,0)
 ;;=N40.0^^105^1170^12
 ;;^UTILITY(U,$J,358.3,23213,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23213,1,3,0)
 ;;=3^Enlarged Prostate w/o Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,23213,1,4,0)
 ;;=4^N40.0
 ;;^UTILITY(U,$J,358.3,23213,2)
 ;;=^5015689
 ;;^UTILITY(U,$J,358.3,23214,0)
 ;;=N40.1^^105^1170^11
 ;;^UTILITY(U,$J,358.3,23214,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23214,1,3,0)
 ;;=3^Enlarged Prostate w/ Lower Urinary Tract Symptoms
 ;;^UTILITY(U,$J,358.3,23214,1,4,0)
 ;;=4^N40.1
 ;;^UTILITY(U,$J,358.3,23214,2)
 ;;=^5015690
 ;;^UTILITY(U,$J,358.3,23215,0)
 ;;=N45.1^^105^1170^13
 ;;^UTILITY(U,$J,358.3,23215,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23215,1,3,0)
 ;;=3^Epididymitis
 ;;^UTILITY(U,$J,358.3,23215,1,4,0)
 ;;=4^N45.1
 ;;^UTILITY(U,$J,358.3,23215,2)
 ;;=^41396
 ;;^UTILITY(U,$J,358.3,23216,0)
 ;;=N45.2^^105^1170^21
 ;;^UTILITY(U,$J,358.3,23216,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23216,1,3,0)
 ;;=3^Orchitis
 ;;^UTILITY(U,$J,358.3,23216,1,4,0)
 ;;=4^N45.2
 ;;^UTILITY(U,$J,358.3,23216,2)
 ;;=^86174
 ;;^UTILITY(U,$J,358.3,23217,0)
 ;;=N45.3^^105^1170^14
 ;;^UTILITY(U,$J,358.3,23217,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23217,1,3,0)
 ;;=3^Epididymo-Orchitis
 ;;^UTILITY(U,$J,358.3,23217,1,4,0)
 ;;=4^N45.3
 ;;^UTILITY(U,$J,358.3,23217,2)
 ;;=^5015707
 ;;^UTILITY(U,$J,358.3,23218,0)
 ;;=Q61.3^^105^1170^22
 ;;^UTILITY(U,$J,358.3,23218,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23218,1,3,0)
 ;;=3^Polycystic Kidney,Unspec
 ;;^UTILITY(U,$J,358.3,23218,1,4,0)
 ;;=4^Q61.3
 ;;^UTILITY(U,$J,358.3,23218,2)
 ;;=^5018797
 ;;^UTILITY(U,$J,358.3,23219,0)
 ;;=R30.0^^105^1170^9
 ;;^UTILITY(U,$J,358.3,23219,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23219,1,3,0)
 ;;=3^Dysuria
 ;;^UTILITY(U,$J,358.3,23219,1,4,0)
 ;;=4^R30.0
 ;;^UTILITY(U,$J,358.3,23219,2)
 ;;=^5019322
 ;;^UTILITY(U,$J,358.3,23220,0)
 ;;=R33.9^^105^1170^28
 ;;^UTILITY(U,$J,358.3,23220,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,23220,1,3,0)
 ;;=3^Urine Retention,Unspec
